Neuromodulation of chronic headaches: position statement from the European Headache Federation

Paolo Martelletti, Rigmor H Jensen, Andrea Antal, Roberto Arcioni, Filippo Brighina, Marina de Tommaso, Angelo Franzini, Denys Fontaine, Max Heiland, Tim P Jürgens, Massimo Leone, Delphine Magis, Koen Paemeleire, Stefano Palmisani, Walter Paulus, Arne May, European Headache Federation, Paolo Martelletti, Rigmor H Jensen, Andrea Antal, Roberto Arcioni, Filippo Brighina, Marina de Tommaso, Angelo Franzini, Denys Fontaine, Max Heiland, Tim P Jürgens, Massimo Leone, Delphine Magis, Koen Paemeleire, Stefano Palmisani, Walter Paulus, Arne May, European Headache Federation

Abstract

The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic tension-type headache, chronic cluster headache, hemicrania continua) is challenging as serious side effects frequently complicate the course of medical treatment and some patients may be even medically intractable. When a definitive lack of responsiveness to conservative treatments is ascertained and medication overuse headache is excluded, neuromodulation options can be considered in selected cases. Here, the various invasive and non-invasive approaches, such as hypothalamic deep brain stimulation, occipital nerve stimulation, stimulation of sphenopalatine ganglion, cervical spinal cord stimulation, vagus nerve stimulation, transcranial direct current stimulation, repetitive transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation are extensively published although proper RCT-based evidence is limited. The European Headache Federation herewith provides a consensus statement on the clinical use of neuromodulation in headache, based on theoretical background, clinical data, and side effect of each method. This international consensus further gives recommendations for future studies on these new approaches. In spite of a growing field of stimulation devices in headaches treatment, further controlled studies to validate, strengthen and disseminate the use of neurostimulation are clearly warranted. Consequently, until these data are available any neurostimulation device should only be used in patients with medically intractable syndromes from tertiary headache centers either as part of a valid study or have shown to be effective in such controlled studies with an acceptable side effect profile.

References

    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D. et al.Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2163–2196.
    1. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Headache Pain. 2013;14:1.
    1. May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ, Task Force EFNS. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13:1066–77.
    1. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009;16:968–981. doi: 10.1111/j.1468-1331.2009.02748.x.
    1. Steiner TJ, Antonaci F, Jensen R, Lainez MJ, Lanteri-Minet M, Valade D. European Headache Federation, Global Campaign against Headache. Recommendations for headache service organisation and delivery in Europe. J Headache and Pain. 2011;12:419–426. doi: 10.1007/s10194-011-0320-x.
    1. Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M, Simmaco M, Smith T, Al-Kaisy A, Arcioni R, Martelletti P. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012;17:393–406.
    1. Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain. 2011;12:593–601.
    1. Schulman EA, Peterlin BL, Lake AE 3rd, Lipton RB, Hanlon A, Siegel S, Levin M, Goadsby PJ, Markley HG. Defining Refractory Migraine: results of the RHSIS Survey of American Headache Society Members. Headache. 2009;49:509–518.
    1. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet. 2005;366:843–55.
    1. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168–70.
    1. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002;125:976–984.
    1. Black D, Dodick DW. Two cases of medically and surgically intractable SUNCT: a reason for caution and argument for a central mechanism. Cephalalgia. 2002;3:201–204.
    1. Jarrar RG, Black DF, Dodick DW, Davis DH. Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology. 2003;60:1360–1362.
    1. Donnet A, Valade D, Regis J. Gamma knife treatment for refractory cluster headache: a prospective open trial. J Neurol Neurosurg Psychiatry. 2005;76:218–221.
    1. Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJ, Gaul C, Goodman AM, Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study. Cephalalgia. 2013. doi: 10.1177/0333102412473667.
    1. Pedersen JL, Barloese M, Jensen RH. Neurostimulation in cluster headache: A review of current progress. Cephalalgia. 2013. [Epub ahead of print] doi: 10.1177/0333102413489040.
    1. Leone M, May A, Franzini A, Broggi G, Dodick D, Rapoport A, Goadsby PJ, Schoenen J, Bonavita V, Bussone G. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia. 2004;24:934–7.
    1. May A, Bahra A, Büchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–78.
    1. May A, Ashburner J, Buchel C. et al.Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 1999;5:836–38.
    1. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 2001;345:1428–29.
    1. Schoenen J, Di Clemente L, Vandenheede M. et al.Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain. 2005;128:940–47.
    1. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology. 2006;67:150–52.
    1. D’Andrea G, Nordera G, Piacentino M. Effectiveness of hypothalamic stimulation in two patients affected by intractable chronic cluster headache. Neurology. 2006;66(suppl 2):A140. abstr.
    1. Benabid A, Seigneuret E, Torres N. Intraventricular stimulation for targets close to the midline: periaqueductal gray, posterior hypothalamus, anterior hypothalamus, subcommissural structures. Acta Neurochir. 2006;148:1–64. abstr.
    1. Starr PA, Barbaro NM, Raskin NH, Ostrem JL. Chronic stimulation of the posterior hypothalamic region for cluster headache: technique and 1-year results in four patients. J Neurosurg. 2007;106:999–1005.
    1. Owen SL, Green AL, Davies P. et al.Connectivity of an effective hypothalamic surgical target for cluster headache. J Clin Neurosci. 2007;14(10):955–60.
    1. Black D, Bartleson J, Torgrimson S, Davis D. Two cases of chronic cluster headache treated successfully with hypothalamic deep brain stimulation. Neurology (abstract) 2007;68(1):A307.
    1. Mateos V, Seijo F, Lozano B. et al.Deep brain stimulation in chronic refractory headaches: first national cases. Neurologia (abstract) 2007;22:96.
    1. Bartsch T, Pinsker MO, Rasche D. et al.Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series. Cephalalgia. 2008;28:285–95.
    1. Fontaine D, Lazorthes Y, Mertens P. et al.Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain. 2010;11:23–31.
    1. Hidding U, May A. Mere surgery will not cure cluster headache: implications for neurostimulation. Cephalalgia. 2011;31:112–15.
    1. Seijo F, Saiz A, Lozano B. et al.Neuromodulation of the posterolateral hypothalamus for the treatment of chronic refractory cluster headache: experience in five patients with a modified anatomical target. Cephalalgia. 2011;31:1634–41.
    1. Leone M, Franzini A, Proietti Cecchini A, Bussone G. Success, failure, and putative mechanisms in hypothalamic stimulation for drug-resistant chronic cluster headache. Pain. 2013;154:89–94.
    1. Leone M, Franzini A, D’Andrea G, Broggi G, Casucci G, Bussone G. Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol. 2005;57:924–27.
    1. Lyons MK, Dodick DW, Evidente VG. Responsiveness of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing to hypothalamic deep brain stimulation. J Neurosurg. 2009;110:279–81.
    1. Bartsch T, Falk D, Knudsen K. et al.Deep brain stimulation of the posterior hypothalamic area in intractable short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) Cephalalgia. 2011;31:1405–08.
    1. Walcott BP, Bamber NI, Anderson DE. Successful treatment of chronic paroxysmal hemicrania with posterior hypothalamic stimulation: technical case report. Neurosurgery. 2009;65:E997.
    1. Headache classification subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004;24(suppl 1):9–160.
    1. Leone M, Franzini A, Broggi G, Mea E, Cecchini AP, Bussone G. Acute hypothalamic stimulation and ongoing cluster headache attacks. Neurology. 2006;67:1844–45.
    1. The deep-brain stimulation for Parkinson’s disease group. Deep-brain stimulation on the subthalamic nucleus or pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345:956–96335.
    1. Fontaine D, Lanteri-Minet M, Ouchchane L. et al.Anatomical location of effective deep brain stimulation electrodes in chronic cluster headache. Brain. 2010;133:1214–23.
    1. Maniyar FH, Starr P, Goadsby PJ. Paroxysmal sneezing after hypothalamic deep brain stimulation for cluster headache. Cephalalgia. 2012;32(8):641–644.
    1. Cortelli P, Guaraldi P, Leone M. et al.Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients. Eur J Neurol. 2007;14:1008–1536.
    1. Vetrugno R, Pierangeli G, Leone M. et al.Effect on sleep of posterior hypothalamus stimulation in cluster headache. Headache. 2007;47:1085–90.
    1. Jürgens T, Leone M, Proietti-Cecchini A. et al.Hypothalamic deep-brain stimulation modulates thermal sensitivity and pain thresholds in cluster headache. Pain. 2009;146:84–90.
    1. May A, Leone M, Boecker H. et al.Hypothalamic deep brain stimulation in positron emission tomography. J Neurosci. 2006;26:3589–93.
    1. May A. Chronic pain may change the structure of the brain. Pain. 2008;137:7–15.
    1. Zhuo M. Cortical excitation and chronic pain. Trends Neurosci. 2008;31:199–207.
    1. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125:1496–509.
    1. Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003;126:1801–13.
    1. Anthony M. Headache and the greater occipital nerve. Clinical neurology and neurosurgery. 1992;94:297–301.
    1. Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F. et al.Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92–6.
    1. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes–prolonged effects from a single injection. Pain. 2006;122:126–9.
    1. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2:217–22.
    1. Lipton R, Goadsby P, Cady R, Aurora SK, Grosberg B, Freitag F. et al.PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia. 2009;29:30.
    1. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31:271–85.
    1. Silberstein S, Dodick D, Saper J, Huh B, Slavin KV, Sharan A. et al.Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32(16):1165–79.
    1. Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol. 2012;11:708–19.
    1. Reed KL, Black SB, Banta CJ 2nd, Will KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010;30:260–71.
    1. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009;72:341–5.
    1. Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache. 2011;51:1191–201.
    1. Magis D, Allena M, Bolla M, De Pasqua V, Remacle JM, Schoenen J. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6:314–21.
    1. Fontaine D, Christophe Sol J, Raoul S, Fabre N, Geraud G, Magne C. et al.Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia. 2011;31:1101–5.
    1. Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. 2008;7:1001–12.
    1. Marin JC, Goadsby P. Response of SUNCT (Short-Lasting Unilateral Neuralgiform Headaches with Conjunctival Injection and Tearing), SUNA (Short-LAsting Unilateral Neuralgifom Headaches with Autonomic Symptoms) and Primary Stabbing Headaches to Occipital Nerve Stimulation (ONS) Neurology. 2010;74:P04.006. abstract.
    1. Shanahan P, Watkins L, Matharu M. Treatment of medically intractable short- lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with autonomic symptoms (SUNA) with occipital nerve stimulation (ONS) in 6 patients. Cephalalgia. 2009;29:150.
    1. Magis D, Bruno MA, Fumal A, Gerardy PY, Hustinx R, Laureys S. et al.Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.
    1. Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–30.
    1. Natsis K, Baraliakos X, Appell HJ, Tsikaras P, Gigis I, Koebke J. The course of the greater occipital nerve in the suboccipital region: a proposal for setting landmarks for local anesthesia in patients with occipital neuralgia. Clinical anatomy. 2006;19:332–6.
    1. Paemeleire K, Van Buyten JP, Van Buynder M, Alicino D, Van Maele G, Smet I. et al.Phenotype of patients responsive to occipital nerve stimulation for refractory head pain. Cephalalgia. 2010;30:662–73.
    1. May A. Headaches with (ipsilateral) autonomic symptoms. J Neurol. 2003;250:1273–8.
    1. Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg. 1981;32:101–7.
    1. Felisati G, Arnone F, Lozza P, Leone M, Curone M, Bussone G. Sphenopalatine endoscopic ganglion block: a revision of a traditional technique for cluster headache. Laryngoscope. 2006;116:1447–50.
    1. Narouze S, Kapural L, Casanova J, Mekhail N. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache. 2009;49:571–7.
    1. Ruskell GL. Orbital passage of pterygopalatine ganglion efferents to paranasal sinuses and nasal mucosa in man. Cells Tissues Organs. 2003;175:223–28.
    1. Oomen KP, Van Wijck AJ, Hordijk GJ, De Ru JA. Effects of radiofrequency thermocoagulation of the sphenopalatine ganglion on headache and facial pain: correlation with diagnosis. J Orofac Pain. 2012;26:59–64.
    1. Narouze SN. Role of sphenopalatine ganglion neuroablation in the management of cluster headache. Curr Pain Headache Rep. 2010;14:160–3.
    1. Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg. 1997;87:876–80.
    1. Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R. et al.Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches - A Narrative Review. Headache. 2013;53:437–46.
    1. Ansarinia M, Rezai A, Tepper SJ, Steiner CP, Stump J, Stanton-Hicks M. et al.Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache. 2010;50:1164–74.
    1. Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49:983–9.
    1. Schytz HW, Barløse M, Guo S, Selb J, Caparso A, Jensen R, Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia. 2013.
    1. Ammons WS, Blair RW, Foreman RD. Vagal afferent inhibition of primate thoracic spinothalamic neurons. J Neurophysiol. 1983;50:926–940.
    1. Thies R, Foreman RD. Inhibition and excitation of thoracic spinoreticular neurons by electrical stimulation of vagal afferent nerves. Exp Neurol. 1983;82:1–16.
    1. Maixner W, Randich A. Role of the right vagal nerve trunk in antinociception. Brain Res. 1984;298:374–377.
    1. Ren K, Randich A, Gebhart GF. Vagal afferent modulation of spinal nociceptive transmission in the rat. J Neurophysiol. 1989;62:401–415.
    1. Randich A, Ren K, Gebhart GF. Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases. J Neurophysiol. 1990;64:1115–1124.
    1. Chandler MJ, Hobbs SF, Bolser DC, Foreman RD. Effects of vagal afferent stimulation on cervical spinothalamic tract neurons in monkeys. Pain. 1991;44:81–87.
    1. Aicher SA, Lewis SJ, Randich A. Antinociception produced by electrical stimulation of vagal afferents: independence of cervical and subdiaphragmatic branches. Brain Res. 1991;542:63–70.
    1. Thurston CL, Randich A. Quantitative characterization and spinal substrates of antinociception produced by electrical stimulation of the subdiaphragmatic vagus in rats. Pain. 1991;44:201–209.
    1. Thurston CL, Randich A. Effects of vagal afferent stimulation on ON and OFF cells in the rostroventral medulla: Relationships to nociception and arterial blood pressure. J Neurophysiol. 1992;67:180–196.
    1. Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31(Suppl 2):S1–6.
    1. Bossut DF, Maixner W. Effects of cardiac vagal afferent electrostimulation on the response of trigeminal and trigeminothalamic neurons to noxious orofacial stimulation. Pain. 1996;65:101–109.
    1. Evans AR, Jones SL, Blair RW. Effects of vagal afferent nerve stimulation on noxious heat-evoked Fos-like immunoreactivity in the rat lumbar spinal cord. J Comp Neurol. 1994;22:490–498.
    1. Nishikawa Y, Koyama N, Yoshida Y, Yokota T. Activation of ascending antinociceptive system by vagal afferent input as revealed in the nucleus ventralis posteromedialis. Brain Res. 1999;833:108–111.
    1. Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK. The effect of vagus nerve stimulation on migraines. J Pain. 2003;4:530–534.
    1. Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392–395.
    1. Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–86.
    1. Ventureyra EC. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst. 2000;16:101–102.
    1. Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm. 2003;110(12):1437–1443.
    1. Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ. Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation. Int J Psychophysiol. 2005;56(1):37–43.
    1. Nesbitt AD, Marin JCA, Tomkins E, Ruttledge MH, Goadsby PJ. Non-invasive vagus nerve stimulation for the treatment of cluster headache: a case series. J Headache Pain. 2013;1(Suppl 1):P231.
    1. Magis D, Gérard P, Schoenen J. Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience. J Headache Pain. 2013;1(Suppl 1):P198.
    1. Nitsche MA, Paulus W. Transcranial direct current stimulation update 2011. Restor Neurol Neurosci. 2011;29:463–492.
    1. Antal A, Paulus W, Nitsche MA. Electrical stimulation and visual network plasticity. Restor Neurol Neurosci. 2011;29:365–374.
    1. Bindman LJ, Lippold OC, Redfearn JW. The Action of Brief Polarizing Currents on the Cerebral Cortex of the Rat (1) during Current Flow and (2) in the Production of Long-Lasting after-Effects. J Physiol. 1964;172:369–382.
    1. Bohotin V, Fumal A, Vandenheede M, Gerard P, Bohotin C, Maertens de Noordhout A, Schoenen J. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain. 2002;125:912–922.
    1. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol. 2011;14:1133–1145.
    1. Creutzfeldt OD, Fromm GH, Kapp H. Influence of transcortical d-c currents on cortical neuronal activity. Exp Neurol. 1962;5:436–452.
    1. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000;527(Pt 3):633–639.
    1. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001;57:1899–1901.
    1. Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002;125:2238–2247.
    1. Antal A, Paulus W. A case of refractory orofacial pain treated by transcranial direct current stimulation applied over hand motor area in combination with NMDA agonist drug intake. Brain Stimul. 2011;4:117–121.
    1. Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011;31:820–828.
    1. Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, Punjaruk W, Thinkhamrop B, Auvichayapat N. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thai. 2012;95:1003–1012.
    1. Dasilva AF, Mendonca ME, Zaghi S, Lopes M, Dossantos MF, Spierings EL, Bajwa Z, Datta A, Bikson M, Fregni F. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012;52:1283–1295.
    1. Priori A, Hallett M, Rothwell JC. Repetitive transcranial magnetic stimulation or transcranial direct current stimulation? Brain Stimul. 2009;2:241–245.
    1. Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007;72:208–214.
    1. Ambrus GG, Al-Moyed H, Chaieb L, Sarp L, Antal A, Paulus W. The fade-in–short stimulation–fade out approach to sham tDCS–reliable at 1 mA for naive and experienced subjects, but not investigators. Brain Stimul. 2012;5:499–504.
    1. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol. 2003;553:293–301.
    1. Nitsche MA, Grundey J, Liebetanz D, Lang N, Tergau F, Paulus W. Catecholaminergic consolidation of motor cortical neuroplasticity in humans. Cereb Cortex. 2004;14:1240–1245.
    1. Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2003;114:2220–2222. author reply 2222–2223.
    1. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.
    1. Thickbroom GW. Transcranial magnetic stimulation and synaptic plasticity: experimental framework and human models. Exp Brain Res. 2007;180:583–93.
    1. Martens JW, Koehler PJ, Vijselaar J. Magnetic flimmers: 'light in the electromagnetic darkness'. Brain. 2013;136:971–9.
    1. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia. 2007;27:1427–39.
    1. Siniatchkin M, Sendacki M, Moeller F. et al.Abnormal changes of synaptic excitability in migraine with aura. Cereb Cortex. 2012;22:2207–16.
    1. Brighina F, Palermo A, Fierro B. Cortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine. J Headache Pain. 2009;10:77–84.
    1. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol. 2012;8:89–99.
    1. Moulton EA, Burstein R, Tully S, Hargreaves R, Becerra L, Borsook D. Interictal dysfunction of a brainstem descending modulatory center in migraine patients. PLoS One. 2008;3:e3799.
    1. Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–80.
    1. Brighina F, Piazza A, Vitello G. et al.rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227:67–71.
    1. Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003;126:1079–91.
    1. Misra UK, Kalita J, Tripathi GM, Bhoi SK. Is β endorphin related to migraine headache and its relief? Cephalalgia. 2013;33(5):316–22.
    1. Zaghi S, Thiele B, Pimentel D. Assessment and treatment of pain with non-invasive cortical stimulation. Restor Neurol Neurosci. 2011;29:439–51.
    1. Dodick DW, Schembri CT, Helmuth M. et al.Transcranial magnetic stimulation for migraine: a safety review. Headache. 2010;50:1153–63.
    1. Richards EM, Payne JL. The management of mood disorders in pregnancy: alternatives to antidepressants. CNS Spectr. 2013 Apr;10:1–11.
    1. Brighina F, Palermo A, Daniele O. et al.High-frequency transcranial magnetic stimulation on motor cortex of patients affected by migraine with aura: a way to restore normal cortical excitability? Cephalalgia. 2010;30:46–52.
    1. Brighina F, Cosentino G, Vigneri S, Talamanca S, Palermo A, Giglia G, Fierro B. Abnormal facilitatory mechanisms in motor cortex of migraine with aura. Eur J Pain. 2011;15:928–35.
    1. de Tommaso M, Stramaglia S, Brighina F, Fierro B, Francesco VD, Todarello O, Serpino C, Pellicoro M. Lack of effects of low frequency repetitive transcranial magnetic stimulation on alpha rhythm phase synchronization in migraine patients. Neurosci Lett. 2011;20:143–7.
    1. Fumal A, Coppola G, Bohotin V. et al.Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients. Cephalalgia. 2006;26:143–149.
    1. de Tommaso M, Brighina F, Fierro B. Effects of high-frequency repetitive transcranial magnetic stimulation of primary motor cortex on laser-evoked potentials in migraine. J Headache Pain. 2010;11:505–12.
    1. Nnoaham KE, Kumbang J. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev. 2008;16(3):CD003222.
    1. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, Hao JX, Terenius L. Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain. 1991;47:295–8.
    1. Walsh DM, Howe TE, Johnson MI, Sluka KA. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev. 2009;15(2):CD006142.
    1. Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2012;3:CD006276.
    1. Khadilkar A, Odebiyi DO, Brosseau L, Wells GA. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain. Cochrane Database Syst Rev. 2008;8(4):CD003008.
    1. Dubinsky RM, Miyasaki J. Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;74:173–6.
    1. Appenzeller O, Atkinson R. Transcutaneous nerve stimulation for the treatment of migraine and other head pain (author’s transl) MMW Munch Med Wochenschr. 1975;117:1953–4.
    1. Solomon S, Guglielmo KM. Treatment of headache by transcutaneous electrical stimulation. Headache. 1985;25:12–5.
    1. Bronfort G, Nilsson N, Haas M, Evans R, Goldsmith CH, Assendelft WJ, Bouter LM. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev. 2004;1(3):CD001878.
    1. Mousavi SA, Mirbod SM, Khorvash F. Comparison between efficacy of imipramine and transcutaneous electrical nerve stimulation in the prophylaxis of chronic tension-type headache: a randomized controlled clinical trial. J Res Med Sci. 2011;16:923–27.
    1. Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, Magis D. Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly device (PREMICE): a multi-centre, randomized, sham-controlled trial. J Headache Pain. 2013;1(Suppl 1):P184.
    1. Ellens DJ, Levy RM. Peripheral neuromodulation for migraine headache. Progress in neurological surgery. 2011;24:109–117. doi: 10.1159/000323890.
    1. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009;161:327–341. doi: 10.1016/j.neuroscience.2009.03.019.
    1. Tomycz ND, Deibert CP, Moossy JJ. Cervicomedullary Junction Spinal Cord Stimulation for Head and Facial Pain. Headache: The Journal of Head and Face Pain. 2011;51:418–425. doi: 10.1111/j.1526-4610.2010.01829.x.
    1. Wolter T, Kiemen A, Kaube H. High cervical spinal cord stimulation for chronic cluster headache. Cephalalgia. 2011;31(11):1170–1180. doi: 10.1177 /0333102411412627.
    1. Gaul C, Jurgens T, May A. Concerning high cervical spinal cord stimulation for chronic cluster headache. Cephalalgia. 2011;31(15):1588–1589. doi: 10.1177/0333102411422384.
    1. Palmisani S, Al-Kaisy A, Arcioni R, Smith T, Negro A, Lambru G, Bandikatla V, Carson E, Martelletti P. A six year retrospective review of occipital nerve stimulation practice - controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain. 2013;14(1):67. doi: 10.1186/1129-2377-14-67.
    1. Goadsby P. Analysis of occipital nerve stimulation in studies of chronic migraine and broader implications of social media in clinical trials. Cephalalgia. 2012;33:214–215.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir